Table 2 Results of clinical blood routine and serological examinations in all patients.

From: Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease

Characteristics

Nemonoxacin group (n = 41)

Moxifloxacin group (n = 27)

p value

Blood routine

 WBC (^109/L)

7.03 (5.04–8.64)

7.80 (6.38–8.96)

0.080

 RBC (^1012/L)

4.66 (4.31–5.01)

4.79 (4.57–5.18)

0.116

 HGB (g/L)

141.00 (122.50–151.00)

144.00 (139.00–152.00)

0.111

 PLT (^109/L)

209.00 (176.50–271.00)

247.00 (192.00–290.00)

0.226

 NEUT# (^10n/L)

4.72 (3.01–6.44)

5.16 (4.26–5.98)

0.361

 NEUT%

66.80 (60.70–74.50)

66.80 (58.80–72.30)

0.726

CRP (mg/L)

3.55 (2.15–10.80)

4.50 (2.33–8.98)

0.758

ESR (mm/h)

11.50 (7.25–40.25)

10.00 (5.00–16.00)

0.245

  1. Data are presented as median (IQR).
  2. IQR interquartile range, WBC white blood cell, RBC red blood cell, HGB hemoglobin, PLT platelet count, NEUT neutrocyte, CRP C-reactive protein, ESR erythrocyte sedimentation rate.
Back to article page